Extended-term animal reports haven't been done to assess the carcinogenic possible of phenylephrine, nor are there other animal or human data concerning mutagenicity. Anticholinergics: Concomitant use of other brokers with anticholinergic properties need to be carried out with warning. Stimulation may be obvious, especially in little ones and geriatric patients. https://zionkmcgr.blogsumer.com/36690184/akorn-cough-syrup-discontinued-an-overview